Both in Pharmaceuticals
Processa Pharmaceuticals vs Acurx Pharmaceuticals
Over the past year PCSA returned −78.7% and ACXP returned −79.6%; their daily moves had a correlation of 0.04.
PCSA −78.7% ACXP −79.6%Growth of $1, one year, split-adjusted
| Metric | PCSA | ACXP |
|---|---|---|
| Price | $1.89 | $1.04 |
| Market cap | $5.3M | $5.7M |
| Today | 0.00% | −2.80% |
| 1 month | +16.7% | −17.5% |
| 6 months | −25.9% | −51.9% |
| Year to date | −34.4% | −58.2% |
| 1 year | −80.6% | −81.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $196.3K | $10.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 60.2% |
| Short % of float | 2.0% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).